NO20022898D0 - Sammensetning for cellespesifikk transfer av aktive substanser - Google Patents
Sammensetning for cellespesifikk transfer av aktive substanserInfo
- Publication number
- NO20022898D0 NO20022898D0 NO20022898A NO20022898A NO20022898D0 NO 20022898 D0 NO20022898 D0 NO 20022898D0 NO 20022898 A NO20022898 A NO 20022898A NO 20022898 A NO20022898 A NO 20022898A NO 20022898 D0 NO20022898 D0 NO 20022898D0
- Authority
- NO
- Norway
- Prior art keywords
- molecules
- several
- cell
- composition
- active substances
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10131145A DE10131145B4 (de) | 2001-06-28 | 2001-06-28 | Zusammensetzung zum zellspezifischen Transfer von Wirkstoffen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20022898D0 true NO20022898D0 (no) | 2002-06-17 |
| NO20022898L NO20022898L (no) | 2002-12-30 |
Family
ID=7689740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20022898A NO20022898L (no) | 2001-06-28 | 2002-06-17 | Sammensetning for cellespesifikk transfer av aktive substanser |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20030044961A1 (no) |
| EP (1) | EP1270586B1 (no) |
| JP (1) | JP2003061693A (no) |
| AT (1) | ATE346859T1 (no) |
| DE (2) | DE10131145B4 (no) |
| ES (1) | ES2275781T3 (no) |
| NO (1) | NO20022898L (no) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10306789A1 (de) * | 2003-02-18 | 2004-08-26 | Responsif Gmbh | Zusammensetzung zur Verabreichung an ein Lebewesen und Verfahren zur Markierung von Mitteln |
| US7468186B2 (en) * | 2005-07-22 | 2008-12-23 | City Of Hope | Polyomavirus cellular epitopes and uses therefor |
| EP2036980A1 (de) * | 2007-09-14 | 2009-03-18 | Gruber, Jens | Herabregulation der Genexpression mittels Nukleinsäure-beladener virusähnlicher Partikel |
| EP2394163B1 (en) | 2009-02-05 | 2020-08-19 | Biogen MA Inc. | Methods for the detection of jc polyoma virus |
| EP2289937A1 (en) | 2009-08-24 | 2011-03-02 | Wilfried Stücker | Production of monoclonal antibodies in vitro |
| EP2548567A1 (en) * | 2011-07-22 | 2013-01-23 | Universitätsklinikum Hamburg-Eppendorf | Polyoma virus JC peptides and proteins in vaccination and diagnostic applications |
| EP2554664A1 (de) | 2011-08-02 | 2013-02-06 | Life Science Inkubator | Verfahren zur Aufreinigung von Virus-ähnlichen Partikeln (VLP) |
| EP2636746A1 (en) | 2012-03-06 | 2013-09-11 | Life Science Inkubator | A novel drug delivery system based on JCV-VLP |
| NO2774991T3 (no) * | 2013-03-06 | 2018-05-05 | ||
| EP3031821A1 (en) | 2014-12-08 | 2016-06-15 | Life Science Inkubator | polyomavirus VLPs with a fusion protein |
| EP3031820A1 (en) | 2014-12-08 | 2016-06-15 | Life Science Inkubator | JC Polyomavirus VLP (virus-like particle) with a targeting peptide |
| CN105194681B (zh) * | 2015-09-17 | 2018-02-09 | 哈尔滨医科大学 | 一种基于ppv病毒样颗粒的纳米递药系统及其制备方法和应用 |
| EP3368694A1 (en) | 2015-10-28 | 2018-09-05 | Life Science Inkubator GmbH | Use of vlp for the detection of nucleic acids |
| CN110462031A (zh) * | 2017-02-02 | 2019-11-15 | 德国灵长类动物研究中心有限公司(Dpz)-莱布尼兹灵长类动物研究所 | 重新靶向病毒或vlp |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5093920A (en) * | 1987-06-25 | 1992-03-03 | At&T Bell Laboratories | Programmable processing elements interconnected by a communication network including field operation unit for performing field operations |
| DE4335025A1 (de) * | 1993-10-14 | 1995-04-20 | Boehringer Ingelheim Int | Endosomolytisch wirksame Partikel |
| US6613749B1 (en) * | 1994-07-26 | 2003-09-02 | Imperial College Innovations Limited | Papovavirus pseudocapsids and use thereof for exogenous material transfer |
| DE19543553B4 (de) * | 1995-11-22 | 2009-04-09 | Deutsches Primatenzentrum Gmbh | VP-Antigene des JC-Virus |
| US6287857B1 (en) * | 1998-02-09 | 2001-09-11 | Genzyme Corporation | Nucleic acid delivery vehicles |
| JP2001222564A (ja) * | 2000-02-09 | 2001-08-17 | Hitachi Ltd | 論理エミュレーションシステム |
| JP2001249824A (ja) * | 2000-03-02 | 2001-09-14 | Hitachi Ltd | 論理エミュレーションプロセッサおよびそのモジュールユニット |
| US20030212022A1 (en) * | 2001-03-23 | 2003-11-13 | Jean-Marie Vogel | Compositions and methods for gene therapy |
| AU2001294890A1 (en) * | 2000-09-25 | 2002-04-02 | Board Of Regents, The University Of Texas System | Pei: dna vector formulations for in vitro and in vivo gene delivery |
| AU2002335667A1 (en) * | 2001-08-03 | 2003-02-17 | Board Of Regents, The University Of Texas System | Modified reoviral therapy |
-
2001
- 2001-06-28 DE DE10131145A patent/DE10131145B4/de not_active Expired - Fee Related
-
2002
- 2002-06-17 NO NO20022898A patent/NO20022898L/no not_active Application Discontinuation
- 2002-06-26 US US10/179,126 patent/US20030044961A1/en not_active Abandoned
- 2002-06-26 JP JP2002186686A patent/JP2003061693A/ja active Pending
- 2002-06-28 DE DE50208824T patent/DE50208824D1/de not_active Expired - Lifetime
- 2002-06-28 EP EP02014449A patent/EP1270586B1/de not_active Expired - Lifetime
- 2002-06-28 AT AT02014449T patent/ATE346859T1/de not_active IP Right Cessation
- 2002-06-28 ES ES02014449T patent/ES2275781T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20030044961A1 (en) | 2003-03-06 |
| EP1270586A3 (de) | 2003-10-15 |
| NO20022898L (no) | 2002-12-30 |
| EP1270586A2 (de) | 2003-01-02 |
| DE10131145A1 (de) | 2003-03-06 |
| EP1270586B1 (de) | 2006-11-29 |
| ES2275781T3 (es) | 2007-06-16 |
| DE50208824D1 (de) | 2007-01-11 |
| ATE346859T1 (de) | 2006-12-15 |
| JP2003061693A (ja) | 2003-03-04 |
| DE10131145B4 (de) | 2005-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20022898L (no) | Sammensetning for cellespesifikk transfer av aktive substanser | |
| ATE548391T1 (de) | Gefangene bindungsproteine als biosensoren | |
| ATE430558T1 (de) | Herstellung von mikrokügelchen | |
| DK1681353T3 (da) | Af adenovirus afledte genoverförselsvehikler indeholdende mindste ét element af adenovirus type 35 | |
| ATE309206T1 (de) | Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen | |
| MY139031A (en) | Vaccine composition comprising virus-like particles of human papillomavirus | |
| DE59913833D1 (de) | Strukturprotein von aav, seine herstellung und verwendung | |
| DE69534669D1 (de) | Nukleinsaeure enthaltende zusammensetzungen, herstellung und verwendung | |
| DE69828045D1 (de) | Verbindungen, ihre herstellung und ihre verwendung für den transfer von nucleinsäuren in zellen | |
| DE69802389D1 (de) | Verbindungen verwendbar als effektoren von neuroexcitatorischen aminosäure-empfindlichen rezeptoren des zentralnervensystems, ihre herstellung and ihre biologischen verwendungen | |
| PT1016711E (pt) | Processo de inactivacao de virus de envelope numa preparacao viral de adenovirus | |
| DE60028022D1 (de) | Herstellung von biologisch aktiven molekülen | |
| DE60023600D1 (de) | Replizierende retrovirale Konstrukte, ihre Herstellung und Verwendungen für den Gentransfer | |
| WO2003000047A3 (en) | Hydrogel beads or capsules as artificial media for insects oviposition and rearing of endoparasitoids | |
| DE60227718D1 (de) | Verwendung von 2-Fuoro-3-Ketoestern zur Herstellung von 3-Fuoro-6,7,8,9-tetrahydro-4H-pyrimidoÄ1,2-aÜpyrimidin-4-onen | |
| DE69837190D1 (de) | Elektroden-Materialien zur Verwendung in Batterien,und Elektroden und Batterien, in denen diese verwendet werden | |
| ATE237585T1 (de) | Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung | |
| ATE223701T1 (de) | Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen | |
| DE60206056D1 (de) | Herstellung von polymerteilchen | |
| AU2001233957A1 (en) | Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (bad) and unipolar depression | |
| DE60033416D1 (de) | Verwendung von hypoestoxiden als antiparasitäre mittel | |
| AU3609800A (en) | Novel formulations of alkyllithiums with improved thermal stability, processes to produce these formulations and processes for using the same to improve stability of living polymer chain ends | |
| HUP9800113A2 (hu) | Transzgenikus vírus | |
| ATE263234T1 (de) | Veränderte, kleine rna-viren | |
| DE60033679D1 (de) | Herstellung von rekombinanten adenoviren und von adenovirus-genbanken |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |